For: | Fouad SA, Esmat S, Omran D, Rashid L, Kobaisi MH. Noninvasive assessment of hepatic fibrosis in Egyptian patients with chronic hepatitis C virus infection. World J Gastroenterol 2012; 18(23): 2988-2994 [PMID: 22736923 DOI: 10.3748/wjg.v18.i23.2988] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v18/i23/2988.htm |
Number | Citing Articles |
1 |
Tomas Koller, Jana Kollerova, Martin Huorka, Iveta Meciarova, Juraj Payer. Noninvasive scoring algorithm to identify significant liver fibrosis among treatment-naive chronic hepatitis C patients. European Journal of Gastroenterology & Hepatology 2014; 26(10): 1108 doi: 10.1097/MEG.0000000000000182
|
2 |
Iraj Shahramian, Manijeh Khalili, Alireza Sargazi, Alireza Dechal, Mostafa Bazi, Masoud Jahantigh, Mojtaba Delaramnasab, Ali Bazi. Non-Invasive Markers of Liver Fibrosis in Children with Chronic Hepatic Disorders. Gene, Cell and Tissue 2020; 7(3) doi: 10.5812/gct.101443
|
3 |
Hanan Mahmoud Fayed, Hasan Sedeek Mahmoud, Abdallah Elaiw Mohamed Ali. <p>The Utility of Retinol-Binding Protein 4 in Predicting Liver Fibrosis in Chronic Hepatitis C Patients in Response to Direct-Acting Antivirals</p>. Clinical and Experimental Gastroenterology 2020; : 53 doi: 10.2147/CEG.S229689
|
4 |
Baris Yilmaz, Huseyin Kayadibi, Abdullah O. Yeniova, Huseyin Koseoglu, Zahide Simsek. The age, bilirubin and albumin (ABA) index: a novel noninvasive index for predicting liver fibrosis in patients with chronic hepatitis C infection. European Journal of Gastroenterology & Hepatology 2021; 33(1S): e290 doi: 10.1097/MEG.0000000000002038
|
5 |
Bassel K. El-Zorkany, Sherif M. Gamal, Sherine A. El-Mofty. Frequency and causes of discontinuation of methotrexate in a cohort of Egyptian patients. The Egyptian Rheumatologist 2013; 35(2): 53 doi: 10.1016/j.ejr.2013.01.003
|
6 |
María Jesús Andrés-Otero, José Manuel Lou-Bonafonte, Jesús Escanero-Marcén, Trinidad Serrano-Aulló, Juan José Puente-Lanzarote. Biomarcadores, índices y algoritmos para el diagnóstico de fibrosis hepática en pacientes con hepatitis crónica por virus C. Revista del Laboratorio Clínico 2015; 8(4): 179 doi: 10.1016/j.labcli.2015.07.004
|
7 |
Ragesh B. Thandassery, Saad Al Kaabi, Madiha E. Soofi, Syed A. Mohiuddin, Anil K. John, Muneera Al Mohannadi, Khalid Al Ejji, Rafie Yakoob, Moutaz F. Derbala, Hamidullah Wani, Manik Sharma, Nazeeh Al Dweik, Mohammed T. Butt, Yasser M. Kamel, Khaleel Sultan, Fuad Pasic, Rajvir Singh. Mean Platelet Volume, Red Cell Distribution Width to Platelet Count Ratio, Globulin Platelet Index, and 16 Other Indirect Noninvasive Fibrosis Scores. Journal of Clinical Gastroenterology 2016; 50(6): 518 doi: 10.1097/MCG.0000000000000489
|
8 |
María Jesús Andrés-Otero, Ignacio De-Blas-Giral, Juan José Puente-Lanzarote, Trinidad Serrano-Aulló, María José Morandeira, Sara Lorente, José Manuel Lou-Bonafonte. Multiple approaches to assess fourteen non-invasive serum indexes for the diagnosis of liver fibrosis in chronic hepatitis C patients. Clinical Biochemistry 2016; 49(7-8): 560 doi: 10.1016/j.clinbiochem.2015.12.017
|
9 |
Keyur Patel, Sumeet K. Asrani, Maria Isabel Fiel, Deborah Levine, Daniel H. Leung, Andres Duarte-Rojo, Jonathan A. Dranoff, Tarek Nayfeh, Bashar Hasan, Tamar H. Taddei, Yahya Alsawaf, Samer Saadi, Abdul Mounaem Majzoub, Apostolos Manolopoulos, Muayad Alzuabi, Jingyi Ding, Nigar Sofiyeva, Mohammad H. Murad, Mouaz Alsawas, Don C. Rockey, Richard K. Sterling. Accuracy of blood-based biomarkers for staging liver fibrosis in chronic liver disease: A systematic review supporting the AASLD Practice Guideline. Hepatology 2025; 81(1): 358 doi: 10.1097/HEP.0000000000000842
|
10 |
Hossein Keyvani, Mehdi Fazlalipour, Seyed Hamid Reza Monavari, Hamid Reza Mollaie. Hepatitis C Virus - Proteins, Diagnosis, Treatment and New Approaches for Vaccine Development. Asian Pacific Journal of Cancer Prevention 2012; 13(12): 5917 doi: 10.7314/APJCP.2012.13.12.5917
|
11 |
Ahmed Cordie, Ahmed Salama, Marwa El‐Sharkawy, Saeed M. El‐Nahaas, Marwa Khairy, Aisha Elsharkawy, Mohamed Hassany, Gamal Esmat. Comparing the efficiency of Fib‐4, Egy‐score, APRI, and GUCI in liver fibrosis staging in Egyptians with chronic hepatitis C. Journal of Medical Virology 2018; 90(6): 1106 doi: 10.1002/jmv.25064
|
12 |
Shelley S Selph, Alexander D Ginsburg, Roger Chou. Impact of contacting study authors to obtain additional data for systematic reviews: diagnostic accuracy studies for hepatic fibrosis. Systematic Reviews 2014; 3(1) doi: 10.1186/2046-4053-3-107
|
13 |
Basem Hasan Elesawy, Amal Abd El hafez, Laila Shehata Dorgham, Ahmad El-Askary. Limited reliability of five non-invasive biomarkers in predicting hepatic fibrosis in chronic HCV mono-infected patients opposed to METAVIR scoring. Pathology - Research and Practice 2014; 210(12): 922 doi: 10.1016/j.prp.2014.07.005
|
14 |
Ahmet Tarik Eminler, Talat Ayyildiz, Kader Irak, Murat Kiyici, Selim Gurel, Enver Dolar, Macit Gulten, Selim G. Nak. AST/ALT ratio is not useful in predicting the degree of fibrosis in chronic viral hepatitis patients. European Journal of Gastroenterology & Hepatology 2015; 27(12): 1361 doi: 10.1097/MEG.0000000000000468
|
15 |
Lamiaa Mobarak, Dalia Omran, Mohammed M. Nabeel, Zeinab Zakaria. Fibro markers for prediction of hepatocellular carcinoma in Egyptian patients with chronic liver disease. Journal of Medical Virology 2017; 89(6): 1062 doi: 10.1002/jmv.24720
|
16 |
AM Attallah, MS Albannan, MM Omran, R Zayed, S Saif, A Farid, M Hassany, A Yosry, D Omran. A panel of a mitogenic (PDGF), biochemical (albumin) and demographic (age) parameters for the non-invasive assessment of hepatic fibrosis. British Journal of Biomedical Science 2019; 76(3): 105 doi: 10.1080/09674845.2019.1600325
|
17 |
Shiow-Ling Wu, Sheng-Chang Wang, Hsiao-Hui Tsou, Hsiang-Wei Kuo, Ing-Kang Ho, Sheng-Wen Liu, Ya-Ting Hsu, Yao-Sheng Chang, Yu-Li Liu, Golo Ahlenstiel. Hepatitis C Virus Infection Influences the S-Methadone Metabolite Plasma Concentration. PLoS ONE 2013; 8(7): e69310 doi: 10.1371/journal.pone.0069310
|
18 |
Anna Egresi, Gabriella Lengyel, Krisztina Hagymási. Options of non-invasive assessment of liver fibrosis based on the clinical data. Orvosi Hetilap 2015; 156(2): 43 doi: 10.1556/OH.2015.30069
|
19 |
Dong Lv, Yanfu Guo, Xia Li, Li Zhang. Increased transferase ratio is associated with adverse cardio-cerebral events in patients with unstable angina: A retrospective cohort study. Medicine 2023; 102(31): e34563 doi: 10.1097/MD.0000000000034563
|
20 |
Banu D. Ozel, Orhan K. Poyrazoğlu, Ahmet Karaman, Hatice Karaman, Engin Altinkaya, Eylem Sevinç, Gökmen Zararsiz. The PAPAS index. European Journal of Gastroenterology & Hepatology 2015; 27(8): 895 doi: 10.1097/MEG.0000000000000379
|
21 |
Ayfer BAKIR, Mustafa GÜNEY, Harun ERDAL, Özlem YAVUZ, Armağan GÜNAL, Mustafa GÜLŞEN, Mehmet Tevfik YAVUZ. Assessment of The Performances of Hepatitis C Virus Viral Markers, Age-Platelet Index and Aspartate aminotransferase to Alanine Aminotransferase Ratio Scores, in Predicting Liver Histopathology. Turkish Journal of Internal Medicine 2021; 3(1): 6 doi: 10.46310/tjim.825814
|
22 |
Natalie Zahr, Allison J. Kwong. Serum Biomarkers of Liver Fibrosis Identify Globus Pallidus Vulnerability. SSRN Electronic Journal 2022; doi: 10.2139/ssrn.4194649
|
23 |
Bassem Refaat, Adel Galal El-Shemi, Ahmed Mohamed Ashshi, Adnan AlZanbagi. Serum Activins and Follistatin during the Treatment of Chronic Hepatitis C Genotypes 1 and 4 and Their Correlations with Viral Load and Liver Enzymes: A Preliminary Report. Gastroenterology Research and Practice 2014; 2014: 1 doi: 10.1155/2014/628683
|
24 |
Natalie M. Zahr, Kent E. Vrana. Peripheral TNFα elevations in abstinent alcoholics are associated with hepatitis C infection. PLOS ONE 2018; 13(2): e0191586 doi: 10.1371/journal.pone.0191586
|
25 |
Allison J. Kwong, Natalie M. Zahr. Serum biomarkers of liver fibrosis identify globus pallidus vulnerability. NeuroImage: Clinical 2023; 37: 103333 doi: 10.1016/j.nicl.2023.103333
|
26 |
P Debnath, S Nair, P Rathi, P Junare, S Jain, S Chandnani, A Singh, Q Contractor. Serum biomarkers as an alternative to vibration controlled transient elastography in liver fibrosis staging in chronic hepatitis C. Acta Gastro Enterologica Belgica 2021; 84(1): 43 doi: 10.51821/84.1.776
|
27 |
Bassel El-Zorkany, Abir Mokbel, Sherif M. Gamal, Maha Mousa, Mohamed Youssef, Ihsane Hmamouchi. Comparison of comorbidities of the Egyptian rheumatoid arthritis patients to the global cohort of the COMORA study: a post-hoc analysis. Clinical Rheumatology 2016; 35(5): 1153 doi: 10.1007/s10067-015-3142-4
|
28 |
Shahira El-Etreby. Fibrosis 4 Score Versus Hyaluronic Acid as Non-Invasive Tools for Assessment of HCV-Related Hepatic Fibrosis: Correlation with Quantitative Morphometric Analysis of Liver Biopsy. Gastroenterology & Hepatology: Open Access 2016; 5(2) doi: 10.15406/ghoa.2016.05.00134
|
29 |
Hanan M. Fayed, Ali A. Ghweil, Mona M. AbdelMeguid. Daclatasvir and Sofosbuvir Therapy Enhance Monocyte Phenotypic Changes in Naive Chronic Hepatitis C Patients: A Prospective Cohort Study. Interdisciplinary Perspectives on Infectious Diseases 2019; 2019: 1 doi: 10.1155/2019/9469567
|
30 |
Eman Abdelsameea, Ayman Alsebaey, Wael Abdel-Razek, Nermin Ehsan, Wesam Morad, Mohsen Salama, Imam Waked. Elastography and serum markers of fibrosis versus liver biopsy in 1270 Egyptian patients with hepatitis C. European Journal of Gastroenterology & Hepatology 2020; 32(12): 1553 doi: 10.1097/MEG.0000000000001672
|
31 |
Natalie M. Zahr, Kilian M. Pohl, Allison J. Kwong, Edith V. Sullivan, Adolf Pfefferbaum. Preliminary Evidence for a Relationship between Elevated Plasma TNFα and Smaller Subcortical White Matter Volume in HCV Infection Irrespective of HIV or AUD Comorbidity. International Journal of Molecular Sciences 2021; 22(9): 4953 doi: 10.3390/ijms22094953
|
32 |
Monika Gudowska, Ewa Gruszewska, Anatol Panasiuk, Bogdan Cylwik, Magdalena Świderska, Robert Flisiak, Maciej Szmitkowski, Lech Chrostek. Selected Noninvasive Markers in Diagnosing Liver Diseases. Laboratory Medicine 2016; 47(1): 67 doi: 10.1093/labmed/lmv015
|
33 |
Xiaobo Liu, Peng Liu. Elevated AST/ALT ratio is associated with all-cause mortality in patients with stable coronary artery disease: a secondary analysis based on a retrospective cohort study. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-13355-2
|
34 |
Minal J Sangwaiya, David IN Sherman, David J Lomas, Philip J Shorvon. Latest developments in the imaging of fibrotic liver disease. Acta Radiologica 2014; 55(7): 802 doi: 10.1177/0284185113510159
|
35 |
Bassem Refaat, Ahmed Mohammed Ashshi, Adel Galal El-Shemi, Adnan AlZanbagi. Effects of chronic hepatitis C genotype 1 and 4 on serum activins and follistatin in treatment naïve patients and their correlations with interleukin-6, tumour necrosis factor-α, viral load and liver damage. Clinical and Experimental Medicine 2015; 15(3): 293 doi: 10.1007/s10238-014-0297-2
|